Published in Obesity and Diabetes Week, June 29th, 2009
"This study examined the long-term actions of the stable GLP-1 receptor agonist (d-Ala(8))GLP-1 and the GIP receptor antagonist (Pro(3))GIP alone and in combination in high fat-fed mice. Mice on high-fat diet for 155 days were injected once daily with (d-Ala(8))GLP-1 or (Pro(3))GIP (25 nmol/kg body weight) for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.